biotech · NSCLC Stage IV · Poliomyelitis
BioMarin Pharmaceutical
Biotech Pharmaceutical Co.,
BioMarin Pharmaceutical clinical programs — 10 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 770 Lindaro Street, San Rafael, CA 94901, US
- Founded
- 1997
- Employees
- 3,171
- Programs
- 40
- Drugs
- 37
- Patents
- 0
BioMarin Pharmaceutical projects
10 ClinicalTrials.gov programs sponsored by BioMarin Pharmaceutical.
BioMarin Pharmaceutical has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Faceptor
Biotech Pharmaceutical Co.,
Breast Cancer Metastatic
2 trials -
Nanocovax
Biotech Pharmaceutical Co.,
SARS-CoV-2 Infection
1 trial -
Olorofim
Biotech Pharmaceutical Co.,
Invasive Aspergillosis
1 trial -
Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV
Biotech Pharmaceutical Co.,
Influenza
1 trial -
Recombinant Human VEGF Receptor-Fc Fusion Protein
Biotech Pharmaceutical Co.,
Neovascular Age-related Macular Degeneration
1 trial -
SARS-CoV-2 mRNA Vaccine
Biotech Pharmaceutical Co.,
COVID-19
1 trial -
Stimus (NNG-DEPO)
Biotech Pharmaceutical Co.,
Anemia
1 trial -
Walvax PCV13-TT
Biotech Pharmaceutical Co.,
Pneumococcal Disease, Invasive
1 trial -
eN-Lac®
Biotech Pharmaceutical Co.,
Perennial Allergic Rhinitis
1 trial -
pegcyte
Biotech Pharmaceutical Co.,
Breast Cancer Female
1 trial
Frequently asked questions
How many clinical projects does BioMarin Pharmaceutical have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.